Rockefeller Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Rockefeller Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$568K	Sell	32,799 -171	-0.5%	-$2.34K	﹤0.01%	2021
2026 Q1	$410K	Sell	32,970 -76,989	-70%	-$1.03M	﹤0.01%	2091
2025 Q4	$1.39M	Buy	+109,959	New	+$1.26M	﹤0.01%	1404
2023 Q1	–	Sell	-1,218	Closed	-$2K	–	2052
2022 Q4	$2K	Sell	1,218 -25	-2%	-$56	﹤0.01%	3537
2022 Q3	$2K	Sell	1,243 -1	-0.1%	-$3	﹤0.01%	3550
2022 Q2	$3K	Buy	+1,244	New	+$4.51K	﹤0.01%	3614

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Rockefeller Capital Management's AMRX Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Amneal Pharmaceuticals (AMRX) stake by 0.52% in Q2 2026, selling an estimated $2.34K and leaving 32,799 shares worth $568K. The position accounts for ﹤0.01% of the portfolio, ranked #2021.

Rockefeller Capital Management first reported a position in AMRX in Q2 2022 and has held it in 6 quarters since. The position peaked at $1.39M in Q4 2025. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Rockefeller Capital Management held 32,799 shares of Amneal Pharmaceuticals worth $568K as of Q2 2026.
Rockefeller Capital Management sold 171 Amneal Pharmaceuticals shares in Q2 2026, an estimated $2.34K.
Amneal Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2021 holding.
Rockefeller Capital Management first reported a position in Amneal Pharmaceuticals in Q2 2022 and has held it in 6 quarters since.
Rockefeller Capital Management's Amneal Pharmaceuticals position peaked at $1.39M in Q4 2025.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.